Northern Financial Advisors’s Gilead Sciences GILD Stock Holding History

Northern Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.17M	Buy	8,406 +3,894	+86%	+$545K	0.85%	36
2025 Q4	$554K	Sell	4,512 -4,652	-51%	-$565K	0.63%	47
2025 Q3	$1.02M	Buy	9,164 +80	+0.9%	+$9.09K	0.53%	51
2025 Q2	$1.01M	Sell	9,084 -38	-0.4%	-$4.04K	0.76%	42
2025 Q1	$1.02M	Buy	9,122 +5,160	+130%	+$532K	0.84%	42
2024 Q4	$366K	Buy	+3,962	New	+$357K	0.29%	84
2024 Q2	–	Sell	-3,378	Closed	-$247K	–	109
2024 Q1	$247K	Sell	3,378 -630	-16%	-$48.4K	0.19%	108
2023 Q4	$325K	Buy	4,008 +592	+17%	+$46.1K	0.27%	91
2023 Q3	$256K	Sell	3,416 -151	-4%	-$11.6K	0.23%	101
2023 Q2	$275K	Sell	3,567 -23	-0.6%	-$1.83K	0.24%	99
2023 Q1	$298K	Buy	3,590 +694	+24%	+$57.5K	0.28%	92
2022 Q4	$249K	Buy	+2,896	New	+$229K	0.28%	85

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Northern Financial Advisors's GILD Position: Q1 2026 in Review

Northern Financial Advisors increased its Gilead Sciences (GILD) stake by 86% in Q1 2026, buying an estimated $545K and bringing the position to 8,406 shares worth $1.17M. The position accounts for 0.85% of the portfolio, ranked #36.

Northern Financial Advisors first reported a position in GILD in Q4 2022 and has held it in 12 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Northern Financial Advisors held 8,406 shares of Gilead Sciences worth $1.17M as of Q1 2026.
Northern Financial Advisors bought 3,894 Gilead Sciences shares in Q1 2026, an estimated $545K.
Gilead Sciences made up 0.85% of Northern Financial Advisors's portfolio in Q1 2026, its #36 holding.
Northern Financial Advisors first reported a position in Gilead Sciences in Q4 2022 and has held it in 12 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Northern Financial Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.